What's in Abeer hassan sharafuddin's pipeline?

Abeer hassan sharafuddin has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Abeer hassan sharafuddin's portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/abeer-hassan-sharafuddin.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Abeer hassan sharafuddin — Portfolio Competitive Intelligence Brief

Abeer hassan sharafuddin pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
platelet rich fibrin	platelet rich fibrin	marketed
connective tissue graft	connective tissue graft	marketed			Surgical/Regenerative Medicine

Therapeutic area mix

Surgical/Regenerative Medicine · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for Abeer hassan sharafuddin:

Cite this brief

Drug Landscape (2026). Abeer hassan sharafuddin — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/abeer-hassan-sharafuddin. Accessed 2026-05-16.